Ivermectin and Clopidogrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ivermectin (ivermectin) and Clopidogrel (clopidogrel). Common drug interactions include fatigue among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ivermectin and Clopidogrel. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Ivermectin?

Ivermectin has active ingredients of ivermectin. eHealthMe is studying from 2,199 Ivermectin users. Check the latest studies of Ivermectin.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

14 people who take Ivermectin and Clopidogrel together, and have interactions are studied.

Ivermectin and Clopidogrel drug interactions.

What are the common drug interactions of Ivermectin and Clopidogrel, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Alopecia (absence of hair from areas of the body)
  3. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  4. Arthralgia (joint pain)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Dehydration (dryness resulting from the removal of water)
  7. Epstein-barr virus infection
  8. Fibrin d dimer increased
  9. Haematocrit increased
  10. Hordeolum (small collection of pus (abscess) on the eyelid)

male:

  1. Anaemia (lack of blood)
  2. Cardiac failure
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Overdose
  6. Renal failure (kidney dysfunction)
  7. Septic shock (shock due to blood infection)
  8. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Urinary tract infection

What are the common drug interactions of Ivermectin and Clopidogrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Drug eruption (adverse drug reaction of the skin)
  3. Leukopenia (less number of white blood cells in blood)

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  3. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  4. Multiple allergies (allergy to multiple agents)
  5. Oral herpes (viral infection of mouth)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. White blood cell count increased
  8. Asthenia (weakness)
  9. Catheter site discharge
  10. Injection site discharge

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 4 people, 28.57%
  2. Bacterial Infection: 2 people, 14.29%
  3. High Blood Pressure: 2 people, 14.29%
  4. Hiv Infection: 2 people, 14.29%
  5. Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 7.14%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.14%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
  8. High Blood Cholesterol: 1 person, 7.14%
  9. Type 2 Diabetes: 1 person, 7.14%
  10. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ivermectin and Clopidogrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ivermectin and Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ivermectin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ivermectin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ivermectin and clopidogrel (the active ingredients of Ivermectin and Clopidogrel, respectively), and Ivermectin and Clopidogrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: